Avalo Therapeutics Correlations

AVTX Stock

USD 7.66 0.56 6.81%

The current 90-days correlation between Avalo Therapeutics and Aerovate Therapeutics is 0.07 (i.e., Significant diversification). The correlation of Avalo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Avalo Therapeutics Correlation With Market

Significant diversification

The correlation between Avalo Therapeutics and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Avalo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avalo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Avalo Stock please use our How to Invest in Avalo Therapeutics guide.

Moving together with Avalo Stock

0.68

CRNX

Crinetics Pharmaceuticals

Pair Corr

Moving against Avalo Stock

0.5	PLX	Protalix Biotherapeutics	Pair Corr
0.43	MLSS	Milestone Scientific Earnings Call This Week	Pair Corr
0.38	GE	GE Aerospace	Pair Corr
0.33	LUCD	Lucid Diagnostics	Pair Corr
0.55	CVX	Chevron Corp	Pair Corr
0.46	CSCO	Cisco Systems	Pair Corr
0.43	MMM	3M Company	Pair Corr
0.31	XOM	Exxon Mobil Corp	Pair Corr

Related Correlations Analysis

	ANAB	ACLX	GPCR	AVTE	ALXO	ANEB	ACRV	PMVP	MOLN	MLYS
ANAB		-0.47	-0.29	-0.46	-0.43	-0.12	-0.28	-0.36	-0.27	-0.1	ANAB
ACLX	-0.47		0.39	0.61	0.4	0.13	0.67	0.44	0.07	0.58	ACLX
GPCR	-0.29	0.39		0.63	0.74	0.21	0.71	0.7	0.68	-0.2	GPCR
AVTE	-0.46	0.61	0.63		0.61	0.41	0.52	0.5	0.26	0.31	AVTE
ALXO	-0.43	0.4	0.74	0.61		0.12	0.57	0.68	0.8	-0.24	ALXO
ANEB	-0.12	0.13	0.21	0.41	0.12		-0.03	0.05	-0.08	0.37	ANEB
ACRV	-0.28	0.67	0.71	0.52	0.57	-0.03		0.7	0.39	0.1	ACRV
PMVP	-0.36	0.44	0.7	0.5	0.68	0.05	0.7		0.56	-0.21	PMVP
MOLN	-0.27	0.07	0.68	0.26	0.8	-0.08	0.39	0.56		-0.59	MOLN
MLYS	-0.1	0.58	-0.2	0.31	-0.24	0.37	0.1	-0.21	-0.59		MLYS
	ANAB	ACLX	GPCR	AVTE	ALXO	ANEB	ACRV	PMVP	MOLN	MLYS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MOLN	+ 0.8	ALXO
ALXO	+ 0.74	GPCR
ACRV	+ 0.71	GPCR
PMVP	+ 0.7	GPCR
PMVP	+ 0.7	ACRV
MOLN	+ 0.68	GPCR

High negative correlations

MLYS	- 0.59	MOLN
ACLX	- 0.47	ANAB
AVTE	- 0.46	ANAB
ALXO	- 0.43	ANAB
PMVP	- 0.36	ANAB
GPCR	- 0.29	ANAB

Risk-Adjusted Indicators

There is a big difference between Avalo Stock performing well and Avalo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Avalo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ANAB	4.32	0.41	0.08	0.23	4.43	(5.41)	9.84	(7.48)	43.41
ACLX	2.33	(0.20)	0.00	(0.31)	0.00	0.00	4.79	(5.21)	10.80
GPCR	3.70	(0.37)	0.00	(0.27)	0.00	0.00	6.92	(10.88)	25.66
AVTE	1.29	0.02	0.04	0.00	1.52	(1.58)	2.07	(3.27)	10.45
ALXO	5.79	(0.79)	0.00	2.90	0.00	0.00	15.43	(13.54)	45.05
ANEB	5.72	0.62	0.10	0.37	5.70	(8.10)	19.58	(10.43)	40.87
ACRV	4.13	(0.16)	0.00	(0.16)	0.00	0.00	10.17	(8.24)	30.57
PMVP	1.83	(0.24)	0.00	(0.29)	0.00	0.00	4.41	(3.31)	16.42
MOLN	2.72	(0.28)	0.00	(0.21)	0.00	0.00	7.84	(7.39)	20.58
MLYS	4.29	0.63	0.17	(0.45)	4.26	(4.97)	10.04	(8.23)	50.53

Avalo Therapeutics Corporate Management

Blake MD	Scientific Advisor	Profile
Barbara Slusher	Founder Board	Profile
Maxim CFA	VP Relations	Profile
Stephen Thomas	VP Discovery	Profile
Christopher Sullivan	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC